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Abstract 45 
Scope 46 
Antibiotic stewardship programmes (ASPs) are necessary in hospitals to improve the 47 
judicious use of antibiotics. While ASPs require complex change of key behaviours on 48 
individual, team, organisation and policy levels, evidence from the behavioural 49 
sciences is underutilised in antibiotic stewardship studies across the world, including 50 
high-income countries (HICs). A consensus procedure was performed to propose 51 
research priority areas for optimising effective implementation of ASPs in hospital 52 
settings, using a behavioural perspective.  53 
Methods 54 
A workgroup for behavioural approaches to ASPs was convened in response to the 55 
fourth call for leading expert network proposals by the Joint Programming Initiative 56 
on Antimicrobial Resistance (JPIAMR). Eighteen clinical and academic specialists in 57 
antibiotic stewardship, implementation science and behaviour change from four 58 
high-income countries with publicly-funded health care systems (that is Canada, 59 
Germany, Norway and the UK), met face-to-face to agree on broad research priority 60 
areas using a structured consensus method. 61 
Question addressed and recommendations 62 
The consensus process on the 10 identified research priority areas resulted in 63 
recommendations that need urgent scientiﬁc interest and funding to optimise 64 
effective implementation of antibiotic stewardship programmes for hospital 65 
inpatients in HICs with publicly-funded health care systems. We suggest and detail, 66 
behavioural science evidence-guided research efforts in the following areas:  1) 67 
Comprehensively identifying barriers and facilitators to implementing antibiotic 68 
stewardship programmes and clinical recommendations intended to optimise 69 
antibiotic prescribing; 2) Identifying actors (‘who’) and actions (‘what needs to be 70 
done’) of antibiotic stewardship programmes and clinical teams; 3) Synthesising 71 
available evidence to support future research and planning for antibiotic stewardship 72 
programmes; 4) Specifying the activities in current antibiotic stewardship 73 
programmes with the purpose of defining a ‘control group’ for comparison with new 74 
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initiatives; 5) Defining a balanced set of outcomes and measures to evaluate the 75 
effects of interventions focused on reducing unnecessary exposure to antibiotics; 6) 76 
Conducting robust evaluations of antibiotic stewardship programmes with built-in 77 
process evaluations and fidelity assessments; 7) Defining and designing antibiotic 78 
stewardship programmes; 8) Establishing the evidence base for impact of antibiotic 79 
stewardship programmes on resistance; 9) Investigating the role and impact of 80 
government and policy contexts on antibiotic stewardship programmes; and 10) 81 
Understanding what matters to patients in antibiotic stewardship programmes in 82 
hospitals. 83 
 Assessment, revisions and updates of our priority-setting exercise should be 84 
considered, at intervals of 2 years. To propose research priority areas in low- and 85 
medium income countries (LIMCs), the methodology reported here could be applied.    86 
 87 
 88 
  89 
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Scope 90 
The proposed overarching priority research areas are intended for researchers, 91 
representatives from funding agencies and policy-makers. These priorities provide 92 
suggestions on what needs urgent scientiﬁc interest and funding to optimise 93 
effective implementation of antibiotic stewardship programmes for hospital 94 
inpatients using theoretical and empirical evidence from behavioural sciences. We 95 
based those suggestions on experiences from high-income countries (HICs) with 96 
publicly-funded health care systems, where most evidence on antibiotic stewardship 97 
come from.  98 
Context 99 
Antibiotic resistance is a globally important problem associated with excess 100 
mortality, morbidity, prolonged hospital stays and increased healthcare costs [1]. 101 
Overuse or inappropriate use of antibiotics drives the development of antibiotic 102 
resistance [2]. The vast majority of human consumption of antibiotics occurs in 103 
primary-care settings and nursing homes [3], but antibiotic resistance has 104 
predominantly been a clinical problem in hospitals which are particularly susceptible 105 
to harbouring multidrug-resistant organisms [4]. Therefore, antibiotic stewardship is 106 
essential to improve the judicious use of antibiotics in hospitals by providing 107 
practitioners with tools to prescribe effective therapy while reducing antibiotic-108 
related adverse events, such as antibiotic resistance [1,4]. 109 
An antibiotic stewardship programme (ASP) is a coherent set of collective 110 
daily actions that promotes using antibiotic agents responsibly, where ‘action’ is 111 
defined as a strategy (i.e. a specific set of coherent interventions) [5]. In practice, 112 
ASPs involve a heterogeneous group of system- and organisation-based actions, so 113 
understandably there is not only substantial transnational variability in the 114 
development and implementation of ASPs [6], but even organisation-level variability 115 
in HICs [7-10]. This suggests a global need to optimise and standardise the 116 
implementation of ASPs. Co-ordinated transnational response efforts are underway 117 
to enhance the implementation (i.e. uptake into practice and policy) of effective 118 
ASPs [4]. The planning of such large-scale quality improvement initiatives first 119 
requires optimising the use of existing research resource management [11]. The 120 
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growing number of research projects on ASPs being conducted and submitted for 121 
publication demonstrates that it is a priority area [12], but a number of important 122 
research gaps still need to be addressed [4]. Addressing high-importance questions 123 
(i.e. research priorities) will reduce avoidable research waste [11]. Core elements 124 
and checklist items for global ASPs, including in LIMCs where most of antibiotics are 125 
prescribed, have been developed [13], but without a behavioural ‘lens’. More robust 126 
qualitative research investigating contextual influences on ASPs is needed from 127 
LMICs to propose research priorities for those countries using behavioural ‘lens’. 128 
An antibiotic stewardship programme requires complex behaviour change; 129 
multiple healthcare providers are required to change multiple behaviours at 130 
different time points in the patient care pathway. Moreover, change is required at 131 
the individual, team, organisation and policy levels to change key behaviours. It has 132 
been widely recognised that evidence from behavioural science can be used to 133 
inform that change [3,4,14,15]. The underlying principle of this need is 134 
understanding the difference between recommendations for appropriate antibiotic 135 
use (the ‘what’) and behaviour change interventions (the ‘how’) [3]. To inform the 136 
development of a more effective health behaviour change intervention (that is a 137 
systematic interference designed to modify how an individual acts), researchers have 138 
started to specify the active ingredients of interventions in terms of their component 139 
behaviour change techniques (BCTs) [16]. BCTs are the observable, replicable 140 
components of behaviour change interventions. We know from a Cochrane review 141 
that interventions to improve the translation of antibiotic use recommendations into 142 
practice are effective in increasing compliance with antibiotic policy and reducing 143 
duration of antibiotic treatment in acute care hospital settings [14]. However, the 144 
review suggests that few of those interventions used effective behaviour change 145 
techniques (such as action planning or feedback), the role of a key stakeholder (i.e. 146 
junior doctors) is mostly overlooked, and interventions are developed at the local 147 
level on an ad hoc basis [14]. One of the main recommendations from the review 148 
included a need to bring together world experts in antibiotic stewardship in 149 
partnership with experts in implementation and social sciences to develop a research 150 
agenda to guide future research efforts to optimise effective implementation of ASPs 151 
in hospital settings [14].  152 
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Question addressed  153 
What are the research priority areas to optimise effective implementation of ASPs in 154 
hospital settings in HICs with publicly-funded health care systems?   155 
Methods 156 
Description of the development group 157 
A transnational multidisciplinary workgroup on behavioural approaches to ASPs was 158 
convened in response to the fourth call for leading experts’ network proposals of the 159 
Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). The steering 160 
committee (CR, JMG, PGD) identified 16 members (all the other co-authors) through 161 
a process of peer knowledge sharing and consultation, through existing research 162 
networks and contacts. Members were invited on the basis of: 1) their recognized 163 
expertise in antibiotic stewardship, behavioural and implementation science, 164 
including clinical leads, senior academic staff or experts for health authorities or 165 
policy-makers, with at least 10 years of experience in their subject area or 2) being 166 
frontline clinical staff, clinical- academic or non-clinical academic staff with extensive 167 
experience in the above three areas and 3) coming from a high-income countries 168 
with publicly funded health care systems. In total, the group included 19 members 169 
from the UK (11), Germany (2), Norway (2) and Canada (4). The members had 170 
different backgrounds, including infectious disease physicians, nurses, researchers; 171 
implementation scientists; health psychologists; intervention design methodologists 172 
and health care service scientists (full list: Appendix 1- Supplementary materials 1).  173 
Consensus procedure  174 
The workgroup met face-to-face on the 27th - 28th April 2017 (in Birmingham, UK) 175 
and 30th- 31st October 2017 (in Aberdeen, UK). Meetings were audio-recorded and 176 
summarized and notes were taken. To ensure the priority-setting team had 177 
necessary information about the context [17], each meeting was guided by an 178 
agenda for activities, including practical group work and presentations of knowledge 179 
synthesis undertaken by the workgroup. The latter included: a non-systematic 180 
review and knowledge synthesis of existing evidence on ASP implementation efforts 181 
worldwide; a systematic review of multi-country studies on barriers and facilitators 182 
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to ASPs in hospitals (PROSPERO registration number CRD42017076425); and the 183 
Cochrane review of interventions to improve antibiotic prescribing to hospital 184 
inpatients [14].  185 
The stages of the priority setting process were informed by existing literature 186 
[18] and are summarised in Figure 1. We used the nominal group technique (NGT) - a 187 
commonly used formal consensus development method involving a highly structured 188 
face-to-face group interaction. Practical benefits for which we chose the NGT 189 
included: immediate dissemination of results to the group [19], giving equal voice to 190 
each participant by encouraging individual input [19], reduction of personality 191 
effects (e.g. influences of a power structure) and creating an environment conducive 192 
to initiation of change [20]. In our experience research needs within the area of 193 
behavioural approaches to ASPs are vast and intertwined. Also, in practice, specific 194 
research questions are likely to vary across systems and specific settings [8]. 195 
Therefore, similar to Healy and colleagues [21], we used a modified James Lind 196 
Alliance (JLA) process [22] that led to suggesting unique broad general prioritisation 197 
research areas rather than specific research questions.  198 
The process protocol is presented in the Supplementary Materials 1. . The 199 
session began the workgroup coordinator (CR) with an introduction to the whole 200 
group and an explanation of the purpose of the activity. Participating members then 201 
split into two equal-sized groups. Each group was allocated one consensus decision-202 
making process facilitator (KG and EMD). Both have been previously involve in a 203 
consensus process, and one facilitator (KG) also had previous experiences with the 204 
JLA process. We selected facilitators with the skills to unite differing perspectives and 205 
spheres of expertise and enabling interaction [23]. To capture experiential 206 
differences in people with similar background, thereby giving rise to new 207 
perspectives, participants with similar areas of expertise were grouped together (e.g. 208 
experts in infectious diseases and health psychology and implementation). At the 209 
same time, to stimulate discussion, each group included sub-groups with at least 210 
three different areas of expertise and we also included a clinical-academic in each 211 
group. Participants were asked to generate specific research ideas in these groups. 212 
For this purpose, in silence, participants wrote down research ideas on provided 213 
sticky notes. They were instructed to write one idea per note and encouraged to use 214 
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as many notes as needed. Each participant presented and brought their research 215 
ideas forward for discussion in their groups by reading them aloud and explaining 216 
their choices. All ideas were collected, numbered and displayed on a flipchart board 217 
by a group facilitator. All participants were then asked to read the ideas generated 218 
by the other group. 219 
Participants were brought together through discussion and inductively 220 
collated overlapping research ideas into topics. In the JLA process of priority setting – 221 
a well-established framework – typically the main focus is to agree the list of the Top 222 
10 priorities for future research [22]. However, to avoid artificial consensus, the 223 
group was not informed about this specific number. Instead, we planned to offer the 224 
group an option to decide how many research priority topics would be carried 225 
forward for ranking and prepared a priori a strategy to reduce the number of 226 
generated topics if necessary (detailed in the Supplementary Materials 1).  227 
After a short break, each participant was provided with a printed copy of the 228 
prioritised research topics and asked to rank these priorities from most to least 229 
important. An e-polling system that collects and summarises responses was used to 230 
collate the ranking of the priority ideas. Responses were submitted using personal 231 
electronic devices. After an interval for another activity, the results were presented 232 
to the group on a large projection screen. A facilitator then guided the participants 233 
through listening to each idea, opinion, and concern and initiated discussion to reach 234 
consensus (i.e. a solution that everyone actively supports, or at least can accept). 235 
Results  236 
Consensus process 237 
The consensus process for research priority setting took place in Aberdeen in 238 
October 2017 and lasted 2.5 hours. Sixteen members generated and collated 239 
research ideas into topics, of which fifteen (one person had to leave an activity early) 240 
ranked the prioritised research topics. Following discussion, the group spontaneously 241 
collated individually-generated overlapping research ideas into 10 research topics, 242 
hence there was no need to consider reducing the numbers of generated topics. 243 
During the discussion of the results of ranking of the prioritised research topics, the 244 
group concluded that the top five research priorities received similar ranking scores; 245 
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priority research areas are inter-dependent, and so research is much needed across 246 
all ten.   247 
The dynamic of each group was different, due to different personalities, 248 
experiences, expertise, backgrounds, communication styles and levels of confidence. 249 
The discussions were however vigorous and each participant took strong ownership 250 
of their own proposed ideas. The presence of a facilitator, with experience in both 251 
behavioural and implementation science, to moderate those discussions ensured 252 
mutual understanding. Placing individuals with similar background and prior 253 
presentations and group activities also facilitated shared understanding. In the next 254 
step, pragmatism was required to collate individual research ideas to reach 255 
acceptable compromises and revision of opinions in the search for consensus. At this 256 
point, the group required the assistance of the second facilitator and an 257 
administrator for record keeping, to ensure full, fair, respectful and equal 258 
participation. 259 
Recommendations 260 
Table 1 shows priorities and ranked research topics grouped into three main 261 
descriptive themes. Individual research ideas are presented in the Supplementary 262 
Materials 2. We would anticipate research teams to select the broad research areas 263 
prioritised and develop a specific research project from them. For example, one 264 
research objective for the top research priority would be: Developing a core outcome 265 
set, reflecting clinicians’ and patients’ views, to enable evaluation of effectiveness of 266 
an intervention to support behaviour change, specified (in terms of Target, Action, 267 
Context, Time, Actor (TACTA)), focused on reducing unnecessary exposure to 268 
antibiotics in hospital patients. Within the second top research priority topic, a 269 
specific research objective could be: Developing and piloting a multicentre, 270 
transnational, cluster-randomised controlled trial to compare short- and long-term 271 
effects of two ASPs with different BCT-specified antibiotic stewardship interventions 272 
in hospital inpatient settings. An example research objective within the third 273 
research topic: Estimating short- and long-term effects of TACTA-specified ASP 274 
behaviours on Gram-negative and Gram-positive bacteria, using a controlled 275 
interventional study design and data-reporting. 276 
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Implications  277 
The main implication of this consensus work is potentially reducing avoidable waste 278 
and inefficiency in research by directing future research to address the proposed 279 
uncertainties of importance [23]. To facilitate this process, participation of a priority-280 
setting team in discussion with the community of interest, to share findings and 281 
experiences, is recommended [17]. Research teams are encouraged to identify 282 
opportunities for building robust proposals focused on comprehensively addressing 283 
research objectives within these priorities. Robust proposals could be informed by 284 
recommendations for avoiding research waste [11]; and guidance on designing and 285 
reporting of ASP intervention studies [24,25], implementation studies [26] and 286 
behaviour change interventions [27,28]. ASPs are a global concern, and hence best 287 
addressed by engaging existing research teams to collaborate internationally and 288 
contribute evidence to answer the prioritised research topics. The JPIAMR Virtual 289 
Research Institute has offered to provide a platform to achieve that by increasing 290 
coordination, improving visibility and facilitating knowledge exchange globally 291 
(https://www.jpiamr.eu/activities/jpiamr-virtual-research-institute/). A promising 292 
innovative solution for contributing generalisable evidence is ‘implementation 293 
laboratories’ [29] - such as for the one proposed for audit and feedback 294 
(http://www.ohri.ca/auditfeedback/). For ASPs this would involve a research team 295 
integrated into healthcare systems undertaking research projects directly relevant to 296 
the healthcare systems’ priorities for ASPs. This could offer a much-needed platform 297 
for moving forward from small-scale studies developed on an ad hoc basis, towards 298 
co-ordinated large-scale initiatives focusing on applied research, to develop, 299 
implement and evaluate theoretically-informed ASPs in different contexts. Sufficient 300 
and sustainable resources to support further research efforts are needed to take this 301 
agenda forward. According to Chalmers et al, “research funders have primary 302 
responsibility for reduction in waste resulting from decisions about what research to 303 
do” [23], hence should be encouraged to integrate set research priorities into their 304 
organisational plans, research strategies and funding calls [23].  305 
Our aim was to further optimise ASPs for hospital inpatients, based on 306 
experiences of research partners from HICs. Globally, the majority of prescribing 307 
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takes place in LIMICs [3]. We fully agree with proposals to advance antibiotic 308 
stewardship research in those countries [4,24] - as evident in the fact that most of 309 
our group members collaborate with research partners in LMICs. However, the 310 
health research capacity strengthening research field with a focus on 311 
implementation science is emerging, and currently evidence bases are not yet 312 
sufficiently advanced to effectively inform health research capacity strengthening 313 
research programme planning [30]. Based on our best knowledge and experiences, 314 
we recognised that implementation of ASPs varies greatly across types of healthcare 315 
systems, let alone LMICs, so inviting a limited number partners from LMICs was likely 316 
to unfairly prioritise specific research needs in their countries. We expect a similar 317 
consensus procedure to be conducted with a range of front-line clinicians and 318 
academics from LMICs with extensive experience with antibiotic prescribing in 319 
partnership with experts in implementation, intervention design and behavioural 320 
sciences from HICs and LMICs. More robust qualitative research investigating 321 
contextual influences on ASPs is needed from LMICs to inform such a consensus 322 
procedure. 323 
We did not include patients whose role in hospital antibiotic stewardship was 324 
traditionally limited, but now is starting to increase [31]. We anticipated that a major 325 
practical challenge to include patients would be a need to overcome patient-326 
reported doubts on their ability to understand antibiotic use-related medical 327 
information [31]. We expect that including patients would affect the completeness 328 
of the prioritised areas; hence this is needed. As recommended by Nasser et al [17], 329 
improving and refining the proposed research priorities should be continued, so we 330 
encourage assessment, revisions and updates of our consensus process at intervals 331 
of 2 years, including involvement of other stakeholders (e.g. patients). Single 332 
systematic literature reviews around each priority topic could be conducted, where 333 
numbers and types of scientific publications could serve as a proxy to quantitatively 334 
assess the impact of our research priority areas. 335 
Conclusions 336 
We propose 10 research priorities areas - shared by clinicians, clinical and non-337 
clinical academics from HICs with publicly-funded health care systems - for future 338 
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research on hospital antibiotic stewardship programmes. For this we focused on a 339 
behavioural science perspective – currently underutilised in antibiotic stewardship 340 
studies [3,14,15,32]. This way we addressed a recognised important gap in 341 
knowledge [14]. We specified how optimising implementation of ASPs will depend 342 
on the use of theoretical and empirical evidence from behavioural science for 343 
knowledge synthesis; investigation of implementation failures; informing the 344 
improved design and evaluation of effectiveness, sustainability and scalability of 345 
ASPs as quality improvement initiatives.  346 
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Figure 1 The stages of the research priorities setting process for antibiotic 368 
stewardship programmes in hospital settings. 369 
Table 1 The prioritised 10 research topics (an overarching aspiration: more impactful 370 
hospital antibiotic stewardship programmes). 371 
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Table 1 The prioritised 10 research topics (an overarching aspiration: more impactful 
hospital antibiotic stewardship programmes) 
Research priority area Overall 
ranking  
Theme I. Establishing the evidence base and understanding current practice in 
antibiotic stewardship programmes: 
Comprehensively identifying barriers and facilitators to implementing 
antibiotic stewardship programmes and clinical recommendations intended 
to optimise antibiotic prescribing (i.e. good clinical practice for antibiotic use).  
4 
Identifying actors (‘who’) and actions (‘what needs to be done’) of antibiotic 
stewardship programmes and clinical teams.  
6 
Synthesising available evidence to support future research and planning for 
antibiotic stewardship programmes.  
7 
Specifying the activities in current antibiotic stewardship programmes with 
the purpose of defining a ‘control group’ for comparison with new initiatives.  
8 
Theme II: Design and evaluation of antibiotic stewardship programmes:  
Defining a balanced set of outcomes and measures to evaluate the effects of 
interventions focused on reducing unnecessary exposure to antibiotics. 
1 
Conducting robust evaluations of antibiotic stewardship programmes with 
built-in process evaluations and fidelity assessments.  
2 
Defining and designing antibiotic stewardship programmes.  5 
Theme III. Research priority topics crosscutting to themes I and II:  
Establishing the evidence base for impact of antibiotic stewardship 
programmes on resistance.  
3 
Investigating the role and impact of government and policy contexts on 
antibiotic stewardship programmes.  
9 
Understanding what matters to patients in antibiotic stewardship 
programmes in hospitals.  
10
¥
 
¥
 The involvement of patients in hospital antibiotic stewardship research has been traditionally 
very limited, hence was ranked as no. 10. This is because patients treated with antimicrobials in 
hospital settings are typically more ill than patients treated in primary care, hence they may have 
less capacity to make their own decisions about their care.
 
 
